By Bhanvi Satija LONDON, Oct 6 (Reuters) – AI-based medical devices will need constant monitoring even after they're approved for use, rather than a single pre-approval safety check, the head of the
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Tom Hals, Max A. Cherney and Stephen Nellis WILMINGTON, Delaware, Oct 5 (Reuters) -…
Oct 5 (Reuters) - KKR & Co Inc: * KKR TO ACQUIRE GEN II FUND…
Oct 5 (Reuters) - L'Oreal has engaged restructuring advisers to explore options for rising US…
TRUMP: TONIGHT I WILL SIGN ORDER TO WAIVE OFF-ROAD REQUIREMENT TO ALLOW ANYONE TO PURCHASE…
VIDEO SHOWS: ARGENTINE SOCCER STAR LIONEL MESSI TRAINING WITH THE NATIONAL TEAM / PLAYER DURING…
Oct 5 (Reuters) - Data center operator DayOne Data Centers filed for an initial public…